Sign up for our free China-Africa Week in Review email newsletter
  • This field is for validation purposes and should be left unchanged.

Follow CAP on Social Media

Listen to the CAP Podcast

Until the U.S. Actually Starts to Ship Vaccines Overseas, Criticism of Chinese Vaccine Distribution Doesn’t Fly With Many in the Global South

U.S. Secretary of State Antony Blinken renewed his criticism of China's so-called "strings attached" vaccine diplomacy around the world during an online roundtable discussion with Japanese media. But the Secretary's comments were not well received among many in the Global South, ...

The Narrative on the Efficacy of Chinese-Made Vaccines is Beginning to Change

Brazil's decision to conduct a real-world experiment that tested the effectiveness of the CoronaVac vaccine made by the Chinese pharmaceutical company Sinovac is contributing to a rapid shift in the perception of whether Chinese-made jabs will protect people from either being hospitalized or dying from ...

Chinese Vaccine Shipments to Africa Increase Slightly, But Still Far Below That of Other Regions Around the World

Chinese vaccine deliveries to Africa reached 20 million doses last week, according to the latest tracking report by the Beijing-based Bridge Consulting. Although that figure is up slightly from previous weeks, Africa still lags far behind Asia Pacific (126.5 million vaccines delivered) and Latin ...

New Joint Pakistani-Chinese COVID Vaccine Launches While Hungary Becomes the Latest Country to Sign a Vaccine Production Deal with China

Residents in Pakistan will now have access to a new COVID-19 vaccine that was jointly developed with China's CanSino as part of an effort to relieve acute vaccine shortages. The new PakVac that launched on Tuesday was reportedly developed in Pakistan under the supervision of CanSino executives ...

With a Second Chinese Vaccine Getting the Nod From the WHO, Pressure Mounts on the U.S. to Get Its Own Vaccine Distribution Drive Going

The World Health Organization granted emergency use approval to Sinovac's COVID-19 vaccine, the second Chinese jab to get the global health body's seal of approval. In a statement on Tuesday, the WHO said Sinovac “meets international standards for safety, efficacy, and ...

Analysis from Cobus van Staden

Sanctions and Anti-Sanctions

For those tracking the development (and high-level normalization) of ‘the new cold war,’ this week has been a doozy. U.S. President Joe Biden departed for the G7 summit in Cornwall with a rare bipartisan win in his pocket. His U.S. Innovation and Competition Act, a $250 billion bill aimed at countering Chinese competition in a number of hi-tech areas like semiconductors and robotics, passed with a 68-32 majority. Some predict that it could ...